View More View Less
  • 1 Médecins Sans Frontières (MSF), Berlin, Germany
  • 2 Médecins Sans Frontières (MSF), London, UK
Restricted access

Abstract

To assist international efforts to address major gaps in the availability and accessibility of quality diagnosis and treatment for multi-drug resistant tuberculosis, Médecins Sans Frontières has adapted an approach combining three sets of interlinked strategies: direct provision of medical care, operational research, and public health advocacy. The activities undertaken are reviewed each in turn, with stress on the ways that they impact upon and consolidate each other. In spite of new opportunities, including technologies which significantly improve diagnosis and new, more patient-centred approaches, a much broader international mobilization is needed in order to confront MDR-TB. It is also questionable as to whether existing technologies are successful enough to provide a solid basis for expanded national programs.

  • 1. World Health Organisation 2011 World TB Report 2011 WHO Geneva.

  • 2. World Health Organisation 2011 Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015 WHO Geneva.

    • Search Google Scholar
    • Export Citation
  • 3. In countries with more than 10 cases. World Health Organisation (2007): Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 Global Report on Surveillance and Response. WHO, Geneva. 7 p.

  • 4. World Health Organisation 2011 World TB Report 2011 WHO Geneva.

  • 5. WHO European Ministerial Forum 2007 The Berlin Declaration on Tuberculosis WHO Copenhagen.

  • 6. World Health Organisation 2006 The Stop TB Strategy: Building on and enhancing DOTS to meet the TB-related Millennium Development Goals WHO Geneva.

    • Search Google Scholar
    • Export Citation
  • 7. Ministerial Meeting of High M/XDR-TB Burden Countries 2009 The Beijing “Call for Action’ on Tuberculosis Control and Patient Care: Together Addressing the Global M/XDRTB Epidemic WHO Geneva.

    • Search Google Scholar
    • Export Citation
  • 8. World Health Assembly 2009 WHA 62.15: Prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis WHO Geneva.

    • Search Google Scholar
    • Export Citation
  • 9. H.S. Cox S. Kalon S. Allamuratova V. Siziare Z. Tigay S. Ruesch-Gerdes K. Karimovich Y. Kebede C. Mills 2007 Multidrug-resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures PLoS ONE 2 11 e1126.

    • Search Google Scholar
    • Export Citation
  • 10. J.C. Brust N.S. Shah M. Scott K. Chaiyachati M. Lygizos T.L. van der Merwe S. Bamber Z. Radebe M. Loveday A.P. Moll B. Margot U.G. Lalloo G.H. Friedland N.R. Gandhi 2012 Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care Int J Tuberc Lung Dis 16 8 9981004.

    • Search Google Scholar
    • Export Citation
  • 11. Lalor MK , Allamuratova S, Althomsons S, Tiegay Z, Khamraev AK, Grieg J, Braker K, du Cros P, Telnov O: Risk factors associated with default from Multi Drug Resistant tuberculosis treatment, Uzbekistan, in patients enrolled between 2003–2008. Presentation at IUATLD conference (2011).

    • Search Google Scholar
    • Export Citation
  • 12. S. Majumdar D. O'Brien N. Hurtado C. Hewison P. du Cros 2011 The ‘frozen state’ of drug-resistant tuberculosis: notes from the field in Abkhazia Intern Med J 41 805808.

    • Search Google Scholar
    • Export Citation
  • 13. H.S. Cox T. Kubica D. Doshetov Y. Kabede S. Ruesch-Gerdes S. Niemann 2005 The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia Respir Res 6 134.

    • Search Google Scholar
    • Export Citation
  • 14. M. Bonnet V. Sizaire Y. Kebede A. Janin D. Doshetov B. Mirzoian A. Arzumanian T. Muminov E. Iona L. Rigouts S. Rüsch-Gerdes F. Varaine 2005 Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries Int J Tuberc Lung Dis 9 11471154.

    • Search Google Scholar
    • Export Citation
  • 15. H.S. Cox J.D. Orozco R. Male S. Ruesch-Gerdes D. Falzon I. Small D. Doshetov Y. Kabede M. Aziz 2004 Multidrug-resistant tuberculosis in central Asia Emerg Infect Dis 10 865872.

    • Search Google Scholar
    • Export Citation
  • 16. D. Balabanova B. Roberts E. Richardson C. Haerpfer M. McKee 2012 Health care reform in the former Soviet Union: Beyond the transition Health Serv Res 47 840864.

    • Search Google Scholar
    • Export Citation
  • 17. World Health Organisation 2011 World TB Report 2011 WHO Geneva.

  • 18. Médecins Sans Frontières 2011 Treating Drug-Resistant TB: What does it take? MSF London.

  • 19. Working Group on New TB Drugs (2012): Drug Pipeline. [Internet.] Last accessed August 21, 2012 at http://www.newtbdrugs.org/pipeline.php.

    • Search Google Scholar
    • Export Citation

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Aug 2020 1 0 0
Sep 2020 0 0 0
Oct 2020 1 0 0
Nov 2020 2 14 5
Dec 2020 0 0 0
Jan 2021 1 2 3
Feb 2021 0 0 0